Cantourage Group SE Stock

Equities

HIGH

DE000A3DSV01

Drug Retailers

Market Closed - Xetra 11:36:26 2024-05-31 am EDT 5-day change 1st Jan Change
7 EUR -1.41% Intraday chart for Cantourage Group SE -2.78% -2.51%
Sales 2023 * 23.6M 25.59M Sales 2024 * 39.2M 42.51M Capitalization 87.29M 94.67M
Net income 2023 * -3M -3.25M Net income 2024 * -2M -2.17M EV / Sales 2023 * 3.58 x
Net cash position 2023 * 2.9M 3.15M Net cash position 2024 * 1.9M 2.06M EV / Sales 2024 * 2.18 x
P/E ratio 2023 *
-28 x
P/E ratio 2024 *
-41.2 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.41%
1 week-2.78%
1 month-10.26%
3 months-10.14%
6 months-13.79%
Current year-2.51%
More quotes
1 week
7.00
Extreme 7
7.20
1 month
6.95
Extreme 6.95
7.60
Current year
5.86
Extreme 5.86
11.00
1 year
5.86
Extreme 5.86
13.80
3 years
5.86
Extreme 5.86
40.50
5 years
5.86
Extreme 5.86
40.50
10 years
5.86
Extreme 5.86
40.50
More quotes
Date Price Change Volume
24-05-31 7 -1.41% 0
24-05-30 7.1 -1.39% 0
24-05-29 7.2 +1.41% 1,500
24-05-28 7.1 -0.70% 497
24-05-27 7.15 -0.69% 3,749

Delayed Quote Xetra, May 31, 2024 at 11:36 am EDT

More quotes
Cantourage Group SE is a Germany-based holding company. The Company offers products in market segments such as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. The object of Cantourage GmbH is the production of and wholesale trade in cannabis-based medicinal preparations and trade in other cannabis products.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7 EUR
Average target price
10 EUR
Spread / Average Target
+42.86%
Consensus

Annual profits - Rate of surprise